A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Clinical trial NCT02799745 · COMPLETED
Trial details
- NCT number
- NCT02799745
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-09
- Primary completion
- 2020-08-28
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.